| Jul 13, 2026 | Apogee Therapeutics, Inc. | DEFM14A | $135.11 | — |
| Jul 2, 2026 | Apogee Therapeutics, Inc. | PREM14A | $135.11 | — |
| Jun 22, 2026 | Apogee Therapeutics, Inc. | 8-K | — | — |
| Apr 25, 2024 | Landos Biopharma, Inc. | DEFM14A | $20.42 | 161% |
| Apr 15, 2024 | Landos Biopharma, Inc. | PREM14A | $20.42 | 161% |
| Jan 18, 2024 | Cerevel Therapeutics Holdings, Inc. | DEFM14A | $45.00 | 73% |
| Jan 5, 2024 | Cerevel Therapeutics Holdings, Inc. | PREM14A | $45.00 | 73% |
| Jan 2, 2024 | ImmunoGen, Inc. | DEFM14A | $31.26 | — |
| Dec 21, 2023 | ImmunoGen, Inc. | PREM14A | $31.26 | — |
| Jun 15, 2021 | Soliton, Inc. | DEFM14A | $22.60 | 100% |
| Jun 4, 2021 | Soliton, Inc. | PREM14A | $22.60 | 115.38% |
| Sep 16, 2019 | Allergan plc | DEFM14A | $120.30 | 63.84% |
| Aug 12, 2019 | Allergan plc | PREM14A | $120.30 | 44.5% |